You are currently browsing:

BREAST CANCER IRELAND SPRING RAFFLE WINNERS 2019

BREAST CANCER IRELAND WOULD LIKE TO THANK ALL WHO SUPPORTED OUR SPRING RAFFLE. THE WINNERS ARE AS FOLLOWS: 1st Prize – Denis Casey, Co Dublin. 2nd Prize – Sinead Noonan, Co Clare. 3rd Prize – H Donoghue, Co Galway. Seller’s Prize – Breda Rooney, Co Meath.

Read More

Simple blood test detects 89% of breast cancer relapses

The results of this study from the University of Leicester and Imperial College London are very encouraging: that earlier detection of a breast cancer survivor’s risk of the disease returning could be possible. For further information, please click the link below: https://www.dailymail.co.uk/health/article-6931131/Simple-blood-test-spot-breast-cancer-return-TWO-YEARS-earlier-current-scans.html?fbclid=IwAR1F1cUMPLxOr7gnZGpKQEusqNkF0dk0iccPPv0FBEaak4yzBKrCxs5Gw9g

Read More

Simple test could predict response to anthracycline chemotherapy for patients with ‘triple negative’ breast cancer

Could this be a turning point in breast cancer research? Researchers at Queen’s University Belfast have found a new biomarker that could predict the effectiveness of a common type of chemotherapy for patients with triple negative breast cancer. To read more about this exciting discovery, click the link below: https://breastcancernow.org/news-and-blogs/news/simple-test-could-predict-response-to-anthracycline-chemotherapy-for-patients-with-%E2%80%98triple-negative%E2%80%99-breast-cancer?utm_source=facebooko&utm_medium=social&utm_campaign=news&utm_content=10042019-link&fbclid=IwAR1_8dY2gWwAG8m7h9QBj7wuEy6DY8EKdhw43n5jweYkPP646pReEphtHQs

Read More

Breast cancer treatments: Current, new and emerging therapies

At the 2019 AACR Foundation Annual Meeting, researchers discussed the landscape of breast cancer treatment. Have a read of the article at the link below – the Breast Cancer Research Foundation outlines the successes, challenges and promising innovations ahead for each breast cancer subtype. https://www.bcrf.org/blog/breast-cancer-treatments-current-new-and-emerging-therapies?fbclid=IwAR2X7R6hL-9zBnvkXK8aslzfNGyTYe_PudRr-R97uDMdgY6AMfiblQ156EM

Read More

FDA approves Atezolizumab for Triple-Negative Breast Cancer

The US FDA has granted accelerated approval of a new treatment for triple-negative breast cancer, which is difficult to treat. Further trials are required, but early studies strongly suggest that patients with triple-negative breast cancer benefit from this combination treatment. For further details, click on the link below: https://www.cancer.gov/news-events/cancer-currents-blog/2019/atezolizumab-triple-negative-breast-cancer-fda-approval?fbclid=IwAR00ZVHpsrp2qMMLx1Z9stNVarNL9Hqs_9WcpWrSO4vgYWFYqZKSKtpYepc     

Read More
X